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Functionalisation of Isoindolinones via a Calcium Catalysed 
Hosomi-Sakurai Allylation
Ashley J. Basson and Mark G. McLaughlin a 
A rapid and functionally tolerant calcium catalysed Hosomi-Sakurai 
reaction has been realised. Employing 1 mol% calcium, allylated 
isoindolinones can be synthesised in high yields and the reaction is 
shown to be tolerant to a range of medicinally relevant functional 
groups including heterocycles. The synthetic utility of the reaction 
has been shown, and a plausible reaction mechanism is provided.
Isoindolinones are a common structural motif found in both 
drugs and natural products alike (Fig. 1).1 For example, 
Lenalidomide is used in the treatment of cancer,2 Taliscanine 
has been shown to have potential as treatment for neurological 
disorders,3 and zopiclone is an approved treatment for 
insomnia. Furthermore, investigational compounds such as A1 
act as inhibitors of the MDM2-p53 protein-protein interaction.4
Figure 1. Biologically Relevant -lactams
Due to their pronounced biological activities against a range of 
disease targets, their synthesis has attracted the attention of 
numerous synthetic chemists (Fig 2).5 Of particular interest is 
the development of catalytic transformations to produce these 
important scaffolds. Copper,6 palladium,7 rhodium,8 platinum9 
and other Lewis acids10 have found use in the synthesis of a 
wide range of isoindolinone scaffolds. Although these methods 
are useful, many of them rely on the ready access to 
functionalised building blocks, as well as typically producing 
mono-functionalised isoindolinones. Furthermore, although 
elegant, many of the procedures suffer from functional group 
intolerances, particularly functional groups with relevance in 
medicinal chemistry.11
Figure 2. Selected Previous Examples
During the course of a medicinal chemistry program focused on 
the development of inhibitors against a metabolic disease 
target, we required ready access to a range of substituted -
lactams bearing a functional group handle for further 
exploitation. Due to our groups’ burgeoning interesting in the 
use of calcium as a sustainable catalyst in synthesis,12 we 
decided to explore the use of 3-hydroxyisoindolinones as easily 
prepared precursors to N-acyliminium ions. We reasoned that 
through catalytic dehydration, these reactive intermediates 
could be produced and subsequently trapped by an allyl 
nucleophile.13 We started our investigation on model substrate 
1a, employing a range of differing calcium catalysts and additive 
to effect the desired transformation (Table 1). We surveyed a 
range of calcium salts to determine the most appropriate 
source for the catalytic reaction, and saw no reaction with 
either CaCl2 or Ca(OH)2. Interestingly we saw a stoichiometric 
a.Faculty of Science & Engineering, Department of Natural Sciences, Manchester 
Metropolitan University, Chester Street, Manchester, M1 5GD, UK
Electronic Supplementary Information (ESI) available: Full experimental conditions 
and copies of spectra are avalable]. See DOI: 10.1039/x0xx00000x
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reaction when Ca(OiPr)2 was used, with yield increasing as 
loading increased.
Figure 3. Optimisation Studies.
a isolated yield b 10 mol% used c reaction at room temp
Gratifyingly, when Ca(NTf2)2 was employed as a catalyst,14 we 
isolated 15% of the desired product after 1 hour.10c Addition of 
nBu4NPF6 further improved the yield,15 as did changing the 
solvent to 1,2-DCE. Further attempts at improving the reaction 
were not successful, including performing the reaction in a 
binary mix of solvents. To ensure the reaction required a 
calcium salt, we attempted the reaction using HNTf2, however 
no reaction was observed. 
With these optimised conditions in hand, we probed the 
substrate scope of the reaction (Figure 4). As observed, both 
electron donating (2a,d) and electron withdrawing (2b,c) 
groups were well tolerated, each providing the allylated 
product in excellent yields and high efficiency. 
Figure 4. Substrate Scope
We next moved our attention onto compound exhibiting a 
range of substitution patterns, with ortho (2e), meta (2f) and 
ortho/para (2g) substituents all tolerated well.  As compounds 
of this 
class 
have 
been 
shown to 
exhibit a 
range of 
biological 
activities,16 we next turned our attention to heterocyclic 
moieties. As shown, the catalyst system is unaffected by 
traditionally difficult functional groups, with morpholine (2h), 
furan (2i), and thiophene (2j) all working well. Furthermore, 
acetal (2k) was also tolerated, affording the allylated product in 
high yield. All the examples shown thus far contained a free NH 
embedded within the lactam core. We therefore decided to 
investigate the effect of nitrogen substitution has on the 
reaction. We focused our attention on either easily removable 
groups (-Me, -Bn) or N-allyl group. As shown, these examples 
also worked well, efficiently providing the desired allylated 
produce in high yields.
Our focus then turned to the use of branched allyl silanes, as 
these will produce compounds with increased levels of diversity 
(R3 = Me or 4-BrPh). The reactions once again proceeded 
smoothly, affording the disubstituted -lactams good yield.
Figure 5. Branched Allylated Products
With the substrate scope completed, we next decided to 
investigate the synthetic applicability of our synthesised 
compounds. Employing Buchwald’s system for Suzuki cross 
couplings of aryl chlorides (2o),17 and using commercial boronic 
acid 4, 5 was obtained in excellent yield.
Scheme 1. Suzuki Cross Coupling
Indolizidines are privileged scaffolds within medicinal chemistry 
and new routes towards these important scaffolds  remains a 
priority.18  We reasoned that due to the high level of structural 
diversity achieved via this methodology, 19 we could produce 
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these important scaffolds easily and in high yields. Using 2p as 
a model, we initially performed a ring closing metathesis with 
Grubb’s 1st generation catalyst.20 This proceeded well and in 
expected high yield. To further increase the utility, we 
performed the reaction in a one-pot fashion. Once again this 
produced the desired compound (6) in nearly identical yield to 
that observed with the isolated.
Scheme 2. One Pot Synthesis of Indolizidines
Finally, as the Hosomi-Sakurai reaction is traditionally non-
catalytic,21 we wanted to perform preliminary studies to 
elucidate the potential mechanism of the reaction. The reaction 
proceeded slowly in the absence of nBu4NPF6, suggesting the 
crucial role the weakly coordinating PF6- ligand has. 
Furthermore, analysis of the crude reaction mixture by 1H NMR 
showed the presence of TMS-OH. Taken together, as well as 
inferring from previous studies,22 a plausible reaction 
mechanism is present below.
The active catalyst A is produced which reacts with the Lewis 
basic hydroxyl group. The resultant N-acyliminium ion B is 
produced, along with a postulated calcium alkoxy species C. The 
N-acyliminium ion is then attacked by the allyl silane affording 
the stabilised cation D. We then reason that due to the 
nucleophilic nature of the ligands in calcium complex C, a facile 
elimination with concomitant reintroduction of PF6-occurs, 
providing the desired compound, releasing TMSOH and 
regenerating catalyst A.
.
Figure 6. Plausible Mechanism
In summary, we have developed a facile and high yielding 
calcium catalysed Hosomi-Sakurai reaction. The reaction 
proceeds well, and is unencumbered by both steric and 
electronic factors. Furthermore, we have shown that both linear 
and branched silanes can react, providing much needed 
diversity of structure. Synthetic applicability has been 
demonstrated, and a plausible reaction mechanism proposed. 
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